We also found that in some studies, the same m6A writer can have opposite effects on the same cancer, such as METTL3 promoting non-small cell lung cancer (84), while also inhibiting lung cancer cell migration and suppressing lung adenocarcinoma progression (86, 87). This evidence concerns the gene METTL3 and lung cancer.